Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons

Microiontophoretic drug application and extracellular recording techniques were used to evaluate the effects of the selective metabotropic glutamate receptor (mGluR) agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylate (1S,3R‐ACPD) on dopamine (DA) neurons in the substantia nigra zona compacta (SNZ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Synapse (New York, N.Y.) N.Y.), 1997-06, Vol.26 (2), p.184-193
Hauptverfasser: Meltzer, Leonard T., Serpa, Kevin A., Christoffersen, Curt L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 193
container_issue 2
container_start_page 184
container_title Synapse (New York, N.Y.)
container_volume 26
creator Meltzer, Leonard T.
Serpa, Kevin A.
Christoffersen, Curt L.
description Microiontophoretic drug application and extracellular recording techniques were used to evaluate the effects of the selective metabotropic glutamate receptor (mGluR) agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylate (1S,3R‐ACPD) on dopamine (DA) neurons in the substantia nigra zona compacta (SNZC) of chloral hydrateanesthetized rats. 1S,3R‐ACPD had a biphasic effect on the firing rate of DA cells, initially decreasing, then increasing the firing rate. 1S,3R‐ACPD also increased the burst‐firing activity of DA neurons. Application of the ionotropic receptor (iGluR) agonists (R,S)‐α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) or N‐methyl‐D‐aspartate (NMDA) increased the firing rates of neurons which had responded to 1S,3R‐ACPD, indicating that mGluRs and iGluRs reside on the same neurons. The initial inhibitory period was not antagonized by systemic haloperidol or iontophoretic bicuculline, indicating a lack of DA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA antagonist, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(f)quinoxaline (NBQX), and the NMDA antagonist, (I)‐3‐(2‐carboxypiperazin‐4‐yl)propyl‐1‐phosphoric acid (CPP), at currents which antagonized AMPA and NMDA, did not antagonize either the inhibitory or excitatory effects of 1S,3R‐ACPD. Application of the metabotropic antagonist (S)‐4‐carboxy‐phenylglycine antagonized both the inhibitory and excitatory effects of 1S‐3R‐ACPD. These results indicate that mGluRs may play a role in the modulation of dopaminergic activity in the SNZC. Synapse 26:184–193, 1997. © 1997 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1098-2396(199706)26:2<184::AID-SYN9>3.0.CO;2-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78981800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78981800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4299-94e006466dfac3d66a58417060c530146434959a943ecce7effe8fb3814d4ffa3</originalsourceid><addsrcrecordid>eNqFkV1rFDEYhYModa3-BGGupL2YNZlkMslahDradaF2xdavq5fMTGYbnS-TDLb_3kx3WS8UCoHwvpycQ86D0AnBc4Jx8vLocpWvjgmWIk6o5EdEygzz44QvkhMi2GJxunobX36_kK_pHM_z9askZg_QbP_gIZphIbKYsYw_Rk-c-4ExpgSzA3QgCSVZls3Q5oP2qui97QdTRptm9KpVXkdWl3rwvY1bXZmwqCLTXZvCeNN3keqqSN-Uxqu7sa8jNxbOq84bFXVmY1VU9YNqTaejTo-279xT9KhWjdPPdvch-nz27ip_H5-vl6v89DwuWSJlLJnGmDPOq1qVtOJcpYKR8G1cphQTxhllMpVKMqrLUme6rrWoCyoIq1hdK3qIXmx9B9v_GrXz0BpX6qZRne5HB5mQgojQw31CwiljhCRBeLUVlrZ3zuoaBmtaZW-BYJhAAUygYOodpt5hCwqScCCAAgigYAIFFDDk67Bmwfb5Ln8sQsd70x2Zv7G_TaNv_8m8J_I_iXdzsI23tsZ5fbO3VfYn8IxmKXy9WEL67Q1fnn35CJ_oH9davq4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16344112</pqid></control><display><type>article</type><title>Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Meltzer, Leonard T. ; Serpa, Kevin A. ; Christoffersen, Curt L.</creator><creatorcontrib>Meltzer, Leonard T. ; Serpa, Kevin A. ; Christoffersen, Curt L.</creatorcontrib><description>Microiontophoretic drug application and extracellular recording techniques were used to evaluate the effects of the selective metabotropic glutamate receptor (mGluR) agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylate (1S,3R‐ACPD) on dopamine (DA) neurons in the substantia nigra zona compacta (SNZC) of chloral hydrateanesthetized rats. 1S,3R‐ACPD had a biphasic effect on the firing rate of DA cells, initially decreasing, then increasing the firing rate. 1S,3R‐ACPD also increased the burst‐firing activity of DA neurons. Application of the ionotropic receptor (iGluR) agonists (R,S)‐α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) or N‐methyl‐D‐aspartate (NMDA) increased the firing rates of neurons which had responded to 1S,3R‐ACPD, indicating that mGluRs and iGluRs reside on the same neurons. The initial inhibitory period was not antagonized by systemic haloperidol or iontophoretic bicuculline, indicating a lack of DA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA antagonist, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(f)quinoxaline (NBQX), and the NMDA antagonist, (I)‐3‐(2‐carboxypiperazin‐4‐yl)propyl‐1‐phosphoric acid (CPP), at currents which antagonized AMPA and NMDA, did not antagonize either the inhibitory or excitatory effects of 1S,3R‐ACPD. Application of the metabotropic antagonist (S)‐4‐carboxy‐phenylglycine antagonized both the inhibitory and excitatory effects of 1S‐3R‐ACPD. These results indicate that mGluRs may play a role in the modulation of dopaminergic activity in the SNZC. Synapse 26:184–193, 1997. © 1997 Wiley‐Liss, Inc.</description><identifier>ISSN: 0887-4476</identifier><identifier>EISSN: 1098-2396</identifier><identifier>DOI: 10.1002/(SICI)1098-2396(199706)26:2&lt;184::AID-SYN9&gt;3.0.CO;2-4</identifier><identifier>PMID: 9131777</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>1S,3R‐ACPD ; 3R-ACPD ; Animals ; Cycloleucine - analogs &amp; derivatives ; Cycloleucine - pharmacology ; Dopamine - metabolism ; Dose-Response Relationship, Drug ; electrophysiology ; ionotropic glutamate receptors ; Male ; Neurons - drug effects ; Neuroprotective Agents - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, Metabotropic Glutamate - drug effects ; Receptors, Metabotropic Glutamate - physiology ; Substantia Nigra - drug effects</subject><ispartof>Synapse (New York, N.Y.), 1997-06, Vol.26 (2), p.184-193</ispartof><rights>Copyright © 1997 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4299-94e006466dfac3d66a58417060c530146434959a943ecce7effe8fb3814d4ffa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291098-2396%28199706%2926%3A2%3C184%3A%3AAID-SYN9%3E3.0.CO%3B2-4$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291098-2396%28199706%2926%3A2%3C184%3A%3AAID-SYN9%3E3.0.CO%3B2-4$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9131777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meltzer, Leonard T.</creatorcontrib><creatorcontrib>Serpa, Kevin A.</creatorcontrib><creatorcontrib>Christoffersen, Curt L.</creatorcontrib><title>Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons</title><title>Synapse (New York, N.Y.)</title><addtitle>Synapse</addtitle><description>Microiontophoretic drug application and extracellular recording techniques were used to evaluate the effects of the selective metabotropic glutamate receptor (mGluR) agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylate (1S,3R‐ACPD) on dopamine (DA) neurons in the substantia nigra zona compacta (SNZC) of chloral hydrateanesthetized rats. 1S,3R‐ACPD had a biphasic effect on the firing rate of DA cells, initially decreasing, then increasing the firing rate. 1S,3R‐ACPD also increased the burst‐firing activity of DA neurons. Application of the ionotropic receptor (iGluR) agonists (R,S)‐α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) or N‐methyl‐D‐aspartate (NMDA) increased the firing rates of neurons which had responded to 1S,3R‐ACPD, indicating that mGluRs and iGluRs reside on the same neurons. The initial inhibitory period was not antagonized by systemic haloperidol or iontophoretic bicuculline, indicating a lack of DA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA antagonist, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(f)quinoxaline (NBQX), and the NMDA antagonist, (I)‐3‐(2‐carboxypiperazin‐4‐yl)propyl‐1‐phosphoric acid (CPP), at currents which antagonized AMPA and NMDA, did not antagonize either the inhibitory or excitatory effects of 1S,3R‐ACPD. Application of the metabotropic antagonist (S)‐4‐carboxy‐phenylglycine antagonized both the inhibitory and excitatory effects of 1S‐3R‐ACPD. These results indicate that mGluRs may play a role in the modulation of dopaminergic activity in the SNZC. Synapse 26:184–193, 1997. © 1997 Wiley‐Liss, Inc.</description><subject>1S,3R‐ACPD</subject><subject>3R-ACPD</subject><subject>Animals</subject><subject>Cycloleucine - analogs &amp; derivatives</subject><subject>Cycloleucine - pharmacology</subject><subject>Dopamine - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>electrophysiology</subject><subject>ionotropic glutamate receptors</subject><subject>Male</subject><subject>Neurons - drug effects</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Metabotropic Glutamate - drug effects</subject><subject>Receptors, Metabotropic Glutamate - physiology</subject><subject>Substantia Nigra - drug effects</subject><issn>0887-4476</issn><issn>1098-2396</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV1rFDEYhYModa3-BGGupL2YNZlkMslahDradaF2xdavq5fMTGYbnS-TDLb_3kx3WS8UCoHwvpycQ86D0AnBc4Jx8vLocpWvjgmWIk6o5EdEygzz44QvkhMi2GJxunobX36_kK_pHM_z9askZg_QbP_gIZphIbKYsYw_Rk-c-4ExpgSzA3QgCSVZls3Q5oP2qui97QdTRptm9KpVXkdWl3rwvY1bXZmwqCLTXZvCeNN3keqqSN-Uxqu7sa8jNxbOq84bFXVmY1VU9YNqTaejTo-279xT9KhWjdPPdvch-nz27ip_H5-vl6v89DwuWSJlLJnGmDPOq1qVtOJcpYKR8G1cphQTxhllMpVKMqrLUme6rrWoCyoIq1hdK3qIXmx9B9v_GrXz0BpX6qZRne5HB5mQgojQw31CwiljhCRBeLUVlrZ3zuoaBmtaZW-BYJhAAUygYOodpt5hCwqScCCAAgigYAIFFDDk67Bmwfb5Ln8sQsd70x2Zv7G_TaNv_8m8J_I_iXdzsI23tsZ5fbO3VfYn8IxmKXy9WEL67Q1fnn35CJ_oH9davq4</recordid><startdate>199706</startdate><enddate>199706</enddate><creator>Meltzer, Leonard T.</creator><creator>Serpa, Kevin A.</creator><creator>Christoffersen, Curt L.</creator><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>199706</creationdate><title>Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons</title><author>Meltzer, Leonard T. ; Serpa, Kevin A. ; Christoffersen, Curt L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4299-94e006466dfac3d66a58417060c530146434959a943ecce7effe8fb3814d4ffa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>1S,3R‐ACPD</topic><topic>3R-ACPD</topic><topic>Animals</topic><topic>Cycloleucine - analogs &amp; derivatives</topic><topic>Cycloleucine - pharmacology</topic><topic>Dopamine - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>electrophysiology</topic><topic>ionotropic glutamate receptors</topic><topic>Male</topic><topic>Neurons - drug effects</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Metabotropic Glutamate - drug effects</topic><topic>Receptors, Metabotropic Glutamate - physiology</topic><topic>Substantia Nigra - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meltzer, Leonard T.</creatorcontrib><creatorcontrib>Serpa, Kevin A.</creatorcontrib><creatorcontrib>Christoffersen, Curt L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Synapse (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meltzer, Leonard T.</au><au>Serpa, Kevin A.</au><au>Christoffersen, Curt L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons</atitle><jtitle>Synapse (New York, N.Y.)</jtitle><addtitle>Synapse</addtitle><date>1997-06</date><risdate>1997</risdate><volume>26</volume><issue>2</issue><spage>184</spage><epage>193</epage><pages>184-193</pages><issn>0887-4476</issn><eissn>1098-2396</eissn><abstract>Microiontophoretic drug application and extracellular recording techniques were used to evaluate the effects of the selective metabotropic glutamate receptor (mGluR) agonist (1S,3R)‐1‐aminocyclopentane‐1,3‐dicarboxylate (1S,3R‐ACPD) on dopamine (DA) neurons in the substantia nigra zona compacta (SNZC) of chloral hydrateanesthetized rats. 1S,3R‐ACPD had a biphasic effect on the firing rate of DA cells, initially decreasing, then increasing the firing rate. 1S,3R‐ACPD also increased the burst‐firing activity of DA neurons. Application of the ionotropic receptor (iGluR) agonists (R,S)‐α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) or N‐methyl‐D‐aspartate (NMDA) increased the firing rates of neurons which had responded to 1S,3R‐ACPD, indicating that mGluRs and iGluRs reside on the same neurons. The initial inhibitory period was not antagonized by systemic haloperidol or iontophoretic bicuculline, indicating a lack of DA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA or γ‐amino‐n‐butyric acid (GABA) involvement in this effect. Combined application of the AMPA antagonist, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(f)quinoxaline (NBQX), and the NMDA antagonist, (I)‐3‐(2‐carboxypiperazin‐4‐yl)propyl‐1‐phosphoric acid (CPP), at currents which antagonized AMPA and NMDA, did not antagonize either the inhibitory or excitatory effects of 1S,3R‐ACPD. Application of the metabotropic antagonist (S)‐4‐carboxy‐phenylglycine antagonized both the inhibitory and excitatory effects of 1S‐3R‐ACPD. These results indicate that mGluRs may play a role in the modulation of dopaminergic activity in the SNZC. Synapse 26:184–193, 1997. © 1997 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>9131777</pmid><doi>10.1002/(SICI)1098-2396(199706)26:2&lt;184::AID-SYN9&gt;3.0.CO;2-4</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0887-4476
ispartof Synapse (New York, N.Y.), 1997-06, Vol.26 (2), p.184-193
issn 0887-4476
1098-2396
language eng
recordid cdi_proquest_miscellaneous_78981800
source MEDLINE; Wiley Journals
subjects 1S,3R‐ACPD
3R-ACPD
Animals
Cycloleucine - analogs & derivatives
Cycloleucine - pharmacology
Dopamine - metabolism
Dose-Response Relationship, Drug
electrophysiology
ionotropic glutamate receptors
Male
Neurons - drug effects
Neuroprotective Agents - pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Metabotropic Glutamate - drug effects
Receptors, Metabotropic Glutamate - physiology
Substantia Nigra - drug effects
title Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T05%3A03%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabotropic%20glutamate%20receptor-mediated%20inhibition%20and%20excitation%20of%20substantia%20nigra%20dopamine%20neurons&rft.jtitle=Synapse%20(New%20York,%20N.Y.)&rft.au=Meltzer,%20Leonard%20T.&rft.date=1997-06&rft.volume=26&rft.issue=2&rft.spage=184&rft.epage=193&rft.pages=184-193&rft.issn=0887-4476&rft.eissn=1098-2396&rft_id=info:doi/10.1002/(SICI)1098-2396(199706)26:2%3C184::AID-SYN9%3E3.0.CO;2-4&rft_dat=%3Cproquest_cross%3E78981800%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16344112&rft_id=info:pmid/9131777&rfr_iscdi=true